Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimensKLOOVER, J. S; DEN BAKKER, M. A; GELDERBLOM, H et al.British journal of cancer. 2004, Vol 90, Num 2, pp 304-305, issn 0007-0920, 2 p.Article

Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancerMALFAIT, T; VAN EIJKEREN, M; VAN MEERBEECK, J. P et al.The European respiratory journal. 2010, Vol 36, Num 4, pp 965-967, issn 0903-1936, 3 p.Article

The effect of radical treatment and rehabilitation on muscle mass and strength: A randomized trial in stages I―III lung cancer patientsSALHI, B; HUYSSE, W; VAN MAELE, G et al.Lung cancer. 2014, Vol 84, Num 1, pp 56-61, issn 0169-5002, 6 p.Article

Occupational risk factors of lung cancer : a hospital based case-control studyDROSTE, J. H. J; WEYLER, J. J; VAN MEERBEECK, J. P et al.Occupational and environmental medicine (London). 1999, Vol 56, Num 5, pp 322-327, issn 1351-0711Article

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancerSENAN, S; CARDENAL, F; VAN MEERBEECK, J. P et al.Annals of oncology. 2011, Vol 22, Num 3, pp 553-558, issn 0923-7534, 6 p.Article

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studiesSURMONT, V; SMIT, E. F; SENAN, S et al.Lung cancer. 2010, Vol 69, Num 3, pp 302-306, issn 0169-5002, 5 p.Article

Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer : A phase I studyDE JONG, W. K; DE JONGE, M. J. A; VAN DER LEEST, A. H. D et al.Lung cancer. 2008, Vol 61, Num 1, pp 123-128, issn 0169-5002, 6 p.Article

Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trialNAVANI, N; NANKIVELL, M; STEPHENS, R. J et al.Thorax. 2010, Vol 65, Num 5, issn 0040-6376, p. 463Article

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer : A phase II study of the european organization for research and treatment of cancer (EORTC 08984)BIESMA, B; MANEGOLD, C; SMIT, H. J. M et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1399-1406, issn 0959-8049, 8 p.Article

A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patientsGIACCONE, G; SMIT, E. F; VAN MEERBEECK, J. P et al.Annals of oncology. 2000, Vol 11, Num 1, pp 109-112, issn 0923-7534Article

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trialVAN SCHIL, P. E; BAAS, P; GAAFAR, R et al.The European respiratory journal. 2010, Vol 36, Num 6, pp 1362-1369, issn 0903-1936, 8 p.Article

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trialsFRANCART, J; VAES, E; HENRARD, S et al.European journal of cancer (1990). 2009, Vol 45, Num 13, pp 2304-2311, issn 0959-8049, 8 p.Article

A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndromeNOORLANDER, I; ELTE, J. W; MANINTVELD, O. C et al.Lung cancer. 2006, Vol 51, Num 2, pp 251-255, issn 0169-5002, 5 p.Article

A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaVAN MEERBEECK, J. P; BAAS, P; DEBRUYNE, C et al.European journal of cancer (1990). 2002, Vol 38, Num 6, pp 779-783, issn 0959-8049Article

Evidence for marked eosinophil degranulation in a case of eosinophilic pneumoniaJORENS, P. G; VAN OVERVELD, F. J; VAN MEERBEECK, J. P et al.Respiratory medicine. 1996, Vol 90, Num 8, pp 505-509, issn 0954-6111Article

The urokinase-type plasminogen activator system in resected non-small-cell lung cancerSALDEN, M; SPLINTER, T. A. W; PETERS, H. A et al.Annals of oncology. 2000, Vol 11, Num 3, pp 327-332, issn 0923-7534Article